Path clear for acellular pertussis vaccines
Noteworthy
Path clear for acellular pertussis vaccines
Positive results in two large trials of several acellular pertussis vaccines have validated the technology, and is likely to result in rapid approval of the new vaccines to replace the currently marketed whole killed vaccines.
The National Institute of Allergy and Infectious Diseases (NIAID) announced results of Phase III trials of acellular pertussis vaccines in Italy